300142 · Walvax Biotechnology Co., Ltd. Class A
16.10
CNYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Yuan23.58B
PE
98.20
EV/EBITDA
36.2
DIV Yield
1.4%
Payout Ratio
140%
MQV Rating
5Very Weak
As at 21/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Expensive
- HALO All
Key Fundamentals
EPS 3 yr Growth
-75.60%
EBITDA Margin
20.00%
Operating Cashflow
¥494m
Free Cash Flow Return
5.30%
ROIC
1.90%
Interest Coverage
N/A
Quick Ratio
2.10
Performance
52 weeks range
Low 10.88 - 16.23
Trade Value (12mth)
US$23,827,068.00
1 week
0%
1 month
14.03%
YTD
33.45%
1 year
14.29%
All time high
96.73
Additional Data
Shares Outstanding (Fully Diluted)
1,599m
HALO Sector
Healthcare
Next Company Report Date
29-Mar-27
Next Ex Dividend Date
24-Jun-26
Next Dividend Pay Date
24-Jun-26
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Neutral
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Xinwo Tengyun | Individual |
| Jun Hui Liu | Individual |
| Yun Chun Li | Individual |
| Geng Yang | Individual |
| Chengdu Xiyun Enterprise Management LP | Private Company |
